Investigator
GlaxoSmithKline
STEVENAGE, England, United Kingdom
Dr Emma Grant, MSci, PhD, GSK
Emma conducted her PhD studies on the collaborative programme between the University of Strathclyde and GlaxoSmithKline. Her research primarily focussed on photoaffinity labelling and the development of a reactive fragment screening platform, to identify tool compounds for target validation. Since graduating in 2020 and being awarded the SCI Young Chemist in Industry Prize, Emma’s work has focussed on the expansion of reactive fragment screening platforms for covalent drug discovery. She now leads the application of these technologies in covalent hit identification to assess target tractability in the Chemical Biology group within GSK.
Disclosure information not submitted.
Reactive fragment platforms for covalent hit identification
Tuesday, May 28, 2024
14:30 - 15:00 CEST